1. Influence of immunosuppression on seroconversion against SARS‐CoV‐2 in two kidney transplant recipients
- Author
-
Wang, Aileen X, Cardona, Orlando Quintero, Ho, Dora Y, Busque, Stephan, and Lenihan, Colin R
- Subjects
Infectious Diseases ,Pneumonia ,Pneumonia & Influenza ,Biodefense ,Vaccine Related ,Lung ,Transplantation ,Prevention ,Emerging Infectious Diseases ,Organ Transplantation ,Kidney Disease ,Renal and urogenital ,Infection ,Good Health and Well Being ,Aged ,Female ,Humans ,Immunocompromised Host ,Immunosuppressive Agents ,Kidney Transplantation ,Middle Aged ,SARS-CoV-2 ,Seroconversion ,Transplant Recipients ,antibodies ,COVID-19 ,immunosuppression ,RT-PCR ,seroconversion ,Clinical Sciences ,Surgery - Abstract
Solid organ transplant recipients are at risk for infectious complications due to chronic immunosuppression. The outbreak of coronavirus disease 2019 (COVID-19) in the United States has raised growing concerns for the transplant patient population. We seek to add to the current limited literature on COVID-19 in transplant recipients by describing the clinical course of two kidney transplant recipients with SARS-CoV-2 infection monitored by both RT-PCR and serology. Through careful adjustment of their immunosuppression regimen, both patients had excellent recovery with intact graft function and development of anti-SARS-CoV-2 antibodies.
- Published
- 2021